Pharmaceutical giants are increasingly turning their attention to low-income populations, launching initiatives to develop and distribute affordable treatments for diseases that disproportionately affect the world’s poor. Advocates hail this as long overdue, while critics remain wary of motives and sustainability.

Health officials in Africa are embracing a novel Ebola vaccination strategy involving smaller doses to stretch supplies and reach more people. The shift could redefine how the continent responds to future outbreaks of one of the world’s deadliest viruses.

Once considered nearly eradicated in much of the world, measles is resurging at alarming rates. Experts warn that a mix of vaccine hesitancy, weakened health systems, and pandemic disruptions have allowed the virus to regain ground.

In isolated communities where malaria was once a death sentence for children, new low-tech interventions and smarter logistics are producing unexpected success. Health workers, often with little more than mobile phones and motorbikes, are changing the odds.

After years of neglect and limited access, a low-cost treatment for sickle cell disease is transforming care for thousands of children in Africa. The results are reshaping the outlook for a disease long considered a death sentence in the region.

Several former U.S. surgeons general have broken their silence about how political interference, censorship, and partisan agendas repeatedly challenged their ability to provide unbiased public health guidance during national crises.

Despite the success of vaccines in fighting diseases like polio and COVID-19, many deadly or chronic illnesses still lack effective vaccines. Scientists explain why some pathogens are far harder to defeat — and what breakthroughs could change that.

After years of steady progress, the global fight against malaria is faltering due to drug resistance, climate change, and stagnant funding. Health experts warn that without urgent intervention, decades of hard-won gains may be reversed, putting millions of lives at renewed risk.

Australia’s rollout of PrEP, a highly effective HIV prevention drug, has led to a notable decline in new infections—but it’s also been accompanied by a steep drop in condom use, raising concerns about other sexually transmitted infections.

Once on the brink of eradication in humans, the parasitic Guinea worm is now infecting dogs in alarming numbers. Scientists fear this unexpected animal reservoir could derail one of the world’s most ambitious disease elimination campaigns.

Innovative tools like vaccines and mobile diagnostics are transforming Ebola outbreak response, offering fresh hope. But experts warn that inconsistent application and mixed messaging could confuse communities and undermine trust.